Pricing

Sirtris Pharmaceuticals Inc (SIRT)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
SUITE 104 CAMBRIDGE, MA 02139

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Sirtris Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs for the treatment of diseases associated with aging, including metabolic diseases, such as type 2 diabetes. Its drug candidates are used to mimic beneficial health effects of calorie restriction by activating SIRT1, which is a member of sirtuins enzymes. The company is developing SRT501, a proprietary formulation of resveratrol; proprietary new chemical entities, which are the new activators of SIRT1; and small molecule modulators of other sirtuins and related pathways for drug development in various areas, including metabolic, cardiovascular, and neurological diseases, as well as cancer.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available